يعرض 1 - 20 نتائج من 2,549 نتيجة بحث عن '"A Dowlati"', وقت الاستعلام: 0.84s تنقيح النتائج
  1. 1
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
    Academic Journal
  6. 6
    Academic Journal
  7. 7
    Academic Journal
  8. 8
    Academic Journal
  9. 9
    Academic Journal
  10. 10
    Academic Journal
  11. 11
    Academic Journal

    المصدر: Fu, P. and Panneerselvam, A. and Clifford, B. and Dowlati, A. and Ma, P. and Zeng, G. and Halmos, B. and Leidner, R. (2012) Simpson's paradox - aggregating and partitioning populations in health disparities of lung cancer patients. Statistical Methods in Medical Research. ISSN 0962-2802

  12. 12
    Academic Journal
  13. 13
    Academic Journal

    المساهمون: Institut Català de la Salut, Spigel DR Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN. Dowlati A University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, OH. Chen Y Cancer and Hematology Centers of Western Michigan, Grand Rapids, MI. Navarro A Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Chih-Hsin Yang J National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan. Stojanovic G Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Journal of Clinical Oncology;42(19); https://doi.org/10.1200/JCO.23.02110; Spigel DR, Dowlati A, Chen Y, Navarro A, Yang JCH, Stojanovic G, et al. RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer. J Clin Oncol. 2024 Jul 1;42(19):2317–26.; https://hdl.handle.net/11351/11652

  14. 14
    Academic Journal

    المساهمون: Institut Català de la Salut, Janku F The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Choong GM Mayo Clinic Rochester, Department of Oncology, Rochester, MN, USA. Opyrchal M Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. Dowlati A University Hospitals of Cleveland, Cleveland, OH, USA. Hierro C Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Rodon J The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Cancers;16(6); https://doi.org/10.3390/cancers16061137; Janku F, Choong GM, Opyrchal M, Dowlati A, Hierro C, Rodon J, et al. A Phase I Study of the Oral Dual-Acting Pan-PI3K/mTOR Inhibitor Bimiralisib in Patients with Advanced Solid Tumors. Cancers (Basel). 2024 Mar 13;16(6):1137.; https://hdl.handle.net/11351/11287; 001191969900001

  15. 15
  16. 16
  17. 17
    Conference
  18. 18
    Academic Journal
  19. 19
    Academic Journal
  20. 20
    Academic Journal